Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
NCT07123155
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Pompe Disease
Interventions
DRUG:
S-606001
DRUG:
Placebo
Sponsor
Shionogi